CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim
Tweet Send to a Friend
(Updated - August 10, 2026 7:40 AM EDT)
Guggenheim analyst Michael Sch lowered the price target on CytomX Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Michael Sch lowered the price target on CytomX Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
